AcelRx Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
60.6 M |
Public Float |
40.79 M |
AcelRx Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.76 |
Market Cap |
$193.34 M |
Shares Outstanding |
78.91 M |
Public Float |
67.11 M |
Address |
351 Galveston Drive Redwood City California 94063 United States |
Employees | - |
Website | http://www.acelrx.com |
Updated | 07/08/2019 |
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of acute pain. Its products include DSUVIA and ZALVISO. The company was founded by Thomas A. |